Latest stories on IMRX
Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival
GlobeNewswire63 · neutralproduct/pr
Immuneering to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Immuneering to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
H.C. Wainwright reiterates Immuneering stock rating on MEK pathway potential
Investing.com Analyst Ratings56 · neutralanalyst
Immuneering says FDA approval of pancreatic cancer treatment ‘good news’
The Fly67 · bullishgeneral
Immuneering GAAP EPS of -$0.27 in-line
Seeking Alpha52 · neutralearnings
Immuneering Corp (IMRX) files 8-K
SEC 8-K50 · neutralgeneral
Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates
Business Insider59 · neutralearnings
Immuneering: A Third (Much Cheaper) Way To Invest In The RAS-RAF-MEK-ERK 'Revolution'
Seeking Alpha73 · bullishproduct/pr
Immuneering Corporation Announces Grants of Inducement Awards
Business Insider50 · neutralgeneral
Immuneering Corporation Announces Grants of Inducement Awards
StockTitan50 · neutralgeneral
Immuneering Appoints Veteran Biotech Leader as New CFO
TipRanks56 · neutralgeneral
Immuneering Corp (IMRX) files 8-K
SEC 8-K50 · neutralgeneral
Immuneering Appoints Andrew Gengos as Chief Financial Officer | IMRX Stock News
StockTitan56 · neutralgeneral
Immuneering Corp (IMRX) files 8-K
SEC 8-K50 · neutralgeneral
Immuneering Advances Atebimetinib With Positive Phase 2a Results
TipRanks68 · bullishproduct/pr
Immuneering Corporation (IMRX) Discusses Positive Atebimetinib ASCO Data Update in First-Line Pancreatic Cancer Transcript
Seeking Alpha73 · bullishproduct/pr
Immuneering’s Atebimetinib Combo Delivers 17.3-Month Median Overall Survival in First-Line Metastatic Pancreatic Cancer—What Sets This Result Apart?
MarketChameleon73 · bullishproduct/pr
Immuneering GAAP EPS of -$0.21 beats by $0.04
Seeking Alpha56 · neutralearnings
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
Business Insider55 · neutralearnings